MedWatch Technologies key facts
as of Oct 2026- Developer of a non-invasive health management platform designed for people suffering from diabetes.
- MedWatch Technologies is valued at approximately $62.5M as of Oct 2026 (last reported valuation).
- It has raised $17.6M; the latest was Early Stage VC ($17.6M) in Mar 2026.
- Notable investors include Front Porch Venture Partners, Solyco Capital, Stead Impact Ventures and Foundation.
- Status: Privately Held (backing).
MedWatch Technologies's last reported valuation, Mar 2026. Nothing priced has surfaced since.
- ·Watch MedWatch Technologies: the Monday email on marks, rounds and moves
MedWatch Technologies funding rounds
No funding rounds for MedWatch Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs MedWatch Technologies
3MedWatch Technologies valuation
MedWatch Technologies's last reported valuation was $62.5 million in Mar 2026. No priced round, secondary trade or fund mark has surfaced since.
MedWatch Technologies investors
3 investors are on record for MedWatch Technologies, including Front Porch Venture Partners, Solyco Capital and Stead Impact Ventures and Foundation.
About MedWatch Technologies
Developer of a non-invasive health management platform designed for people suffering from diabetes. The company's platform monitors glucose levels and provides customers with new tools to continuously adjust their diet and lifestyle in response to their immediate glucose condition, combines biosensing and AI coaching to deliver a comprehensive proactive health management experience, enabling patients to monitor blood glucose levels affordably, and with less discomfort.
- Sector
- Healthcare
- HQ
- Las Vegas, NV, United States
- Founded
- 2022
- Website
- medwatchtech.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.